These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Effects of acute and chronic administration of a new potent antagonist of growth hormone-releasing hormone in rats: mechanisms of action. Kovacs M; Zarándi M; Halmos G; Groot K; Schally AV Endocrinology; 1996 Dec; 137(12):5364-9. PubMed ID: 8940358 [TBL] [Abstract][Full Text] [Related]
26. Synthetic growth hormone-releasing hormone (GHRH 1-44) in the differential diagnosis between hypothalamic and pituitary GH deficiency. Bozzola M; Tatò L; Cisternino M; Nava C; Valtorta A; Chiesa M; Severi F; Gaburro D J Endocrinol Invest; 1986 Dec; 9(6):503-6. PubMed ID: 3106460 [TBL] [Abstract][Full Text] [Related]
27. The role of pituitary ghrelin in growth hormone (GH) secretion: GH-releasing hormone-dependent regulation of pituitary ghrelin gene expression and peptide content. Kamegai J; Tamura H; Shimizu T; Ishii S; Tatsuguchi A; Sugihara H; Oikawa S; Kineman RD Endocrinology; 2004 Aug; 145(8):3731-8. PubMed ID: 15087428 [TBL] [Abstract][Full Text] [Related]
28. Plasma growth hormone responses to growth hormone-releasing hormone in children of short stature. Tsai WY; Chen SH; Lee JS Taiwan Yi Xue Hui Za Zhi; 1989 Aug; 88(8):801-5. PubMed ID: 2512368 [TBL] [Abstract][Full Text] [Related]
29. Neurotransmitter modulation of the GHRH-GH axis. García-Tornadu I; Risso G; Perez-Millan MI; Noain D; Diaz-Torga G; Low MJ; Rubinstein M; Becu-Villalobos D Front Horm Res; 2010; 38():59-69. PubMed ID: 20616496 [TBL] [Abstract][Full Text] [Related]
30. History to the discovery of ghrelin. Bowers CY Methods Enzymol; 2012; 514():3-32. PubMed ID: 22975043 [TBL] [Abstract][Full Text] [Related]
31. [Behavior of growth hormone after stimulation with growth hormone releasing hormone (GHRH) in children with disorders of the hypothalamo-hypophyseal axis and girls with Turner syndrome]. Schmitt K; Schober E; Birnbacher R; Frisch H Klin Padiatr; 1996; 208(1):29-34. PubMed ID: 8851324 [TBL] [Abstract][Full Text] [Related]
32. Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level. Popovic V; Damjanovic S; Micic D; Djurovic M; Dieguez C; Casanueva FF J Clin Endocrinol Metab; 1995 Mar; 80(3):942-7. PubMed ID: 7883854 [TBL] [Abstract][Full Text] [Related]
33. Aspects of the neuroendocrine control of growth hormone secretion in ageing mammals. Müller EE; Cella SG; De Gennaro Colonna V; Parenti M; Cocchi D; Locatelli V J Reprod Fertil Suppl; 1993; 46():99-114. PubMed ID: 8100277 [TBL] [Abstract][Full Text] [Related]
34. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly. Losa M; Schopohl J; König A; Müller OA; von Werder K J Clin Endocrinol Metab; 1986 Aug; 63(2):475-80. PubMed ID: 3088026 [TBL] [Abstract][Full Text] [Related]
35. [Diagnostic use of the GRF test in the study of GH secretion]. Ramos M; Fernández A; Ferrández A; Mayayo E; Guallar A An Esp Pediatr; 1987 Oct; 27(4):269-73. PubMed ID: 2892455 [TBL] [Abstract][Full Text] [Related]
36. Ghrelin and growth hormone (GH) secretagogues potentiate GH-releasing hormone (GHRH)-induced cyclic adenosine 3',5'-monophosphate production in cells expressing transfected GHRH and GH secretagogue receptors. Cunha SR; Mayo KE Endocrinology; 2002 Dec; 143(12):4570-82. PubMed ID: 12446584 [TBL] [Abstract][Full Text] [Related]
37. Partial reversibility of growth hormone (GH) deficiency in the GH-releasing hormone (GHRH) knockout mouse by postnatal treatment with a GHRH analog. Alba M; Schally AV; Salvatori R Endocrinology; 2005 Mar; 146(3):1506-13. PubMed ID: 15564325 [TBL] [Abstract][Full Text] [Related]
38. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly. Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226 [TBL] [Abstract][Full Text] [Related]
39. Secretory mechanisms of growth hormone (GH)-releasing peptide-, GH-releasing hormone-, and thyrotropin-releasing hormone-induced GH release in patients with acromegaly. Hanew K; Utsumi A; Tanaka A; Ikeda H; Yokogoshi Y J Clin Endocrinol Metab; 1998 Oct; 83(10):3578-83. PubMed ID: 9768668 [TBL] [Abstract][Full Text] [Related]
40. Somatostatin pretreatment enhances growth hormone (GH) responsiveness to GH-releasing hormone: a potential new diagnostic approach to GH deficiency. Tzanela M; Guyda H; Van Vliet G; Tannenbaum GS J Clin Endocrinol Metab; 1996 Jul; 81(7):2487-94. PubMed ID: 8675565 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]